Why Abbey Barrett's Mum Wants More Federal Government Help Funding Brain Cancer Research
The Barrett family's daily ritual is a poignant reminder of their loss. Every evening, they place a colorful sticker on their lounge room wall, symbolizing their resilience in the face of their daughter and sister, Abbey's, tragic death from brain cancer 18 months ago. At just 11 years old, Abbey's life was cut short, leaving her mother, Justine, father, Rick, and sisters, Willow and Tasmin, grappling with profound grief.
Justine, a pillar of strength, shares her family's story with the hope of advocating for change. She emphasizes the emotional toll of witnessing her child's suffering, highlighting the need for voluntary assisted dying for children. The Barretts' journey underscores the complex interplay between grief, family dynamics, and the challenges of navigating medical decisions.
Abbey's battle with brain cancer began with subtle symptoms. At 10, she experienced fatigue and hand tremors, initially attributed to normal childhood ailments. However, an MRI revealed a devastating truth: a massive brain tumor the size of a fist wrapped around her brain stem. The family's shock and disbelief were palpable, as they grappled with the surreal transition from a life of Lego and books to one of medications and cancer brochures.
Despite the medical team's support, the Barretts faced the daunting task of making critical decisions regarding Abbey's care. Justine reflects on the harrowing experience, emphasizing the life-or-death consequences of their choices. Abbey's passing at home, in her mother's arms, marked a bittersweet moment, as the family attempted to make her final days as gentle as possible.
The Barretts' story is a poignant reminder of the emotional and practical challenges faced by families dealing with childhood cancer. Justine's advocacy extends beyond personal grief, as she strives to normalize death and grieving for her other daughters, Willow and Tasmin. She acknowledges the profound impact of their sister's loss, noting the struggles they've endured since.
The statistics surrounding brain cancer are alarming. Despite being described as 'rare,' it accounts for approximately 2% of all cancers. In 2023 alone, 1,579 Australians succumbed to brain cancer, surpassing the number of road crash fatalities. This disease disproportionately affects children under 14, making it the leading cause of death among Australian children in this age group.
The five-year survival rates for brain cancer have improved marginally over the last three decades, rising from 19% (1990-1994) to 23% (2015-2019). However, the low survivability and flat curve of these statistics underscore the grim reality of the disease.
Advancements in treating brain cancer are promising. Surgical techniques have improved, and new methods to cross the blood-brain barrier offer hope. Dr. Rosemary Harrup, a medical oncologist, highlights the challenges posed by the blood-brain barrier, which protects the brain from foreign materials. An international study utilizing ultrasound to temporarily open the barrier, combined with chemotherapy, shows promising results.
The Menzies Institute's Associate Professor Phillippa Taberlay and her team are delving into the DNA level, focusing on a type of childhood cancer called medulloblastoma. They aim to understand the altered gene expression caused by epigenetic dysregulation, which could lead to breakthroughs in treating brain cancers and potentially other cancers.
The funding landscape for brain cancer research is concerning. Clinical trials, offering hope to cancer patients, face limited funding. Dr. Harrup notes the disparity in access to clinical trials based on location, with major cities providing more opportunities than rural areas. The Brain Tumour Alliance Australia estimates the economic burden of brain cancer in 2025 at $850 million, projecting a staggering $3.2 billion by 2050 if trends persist.
The alliance advocates for $200 million over 10 years for brain cancer research and trials, and up to $10 million for improved clinical care, including specialized nurse funding. Mr. Cardinal emphasizes the disproportionate burden and complexity of brain cancer, highlighting the mismatch between funding and policy approaches.
The Australian government's commitment to brain cancer research is evident through the Australian Brain Cancer Mission, which invested $126 million over 10 years. Federal Health Minister Mark Butler expresses a commitment to further action, acknowledging the need for improved access to treatments, especially for children with brain cancer.
Justine's advocacy serves as a powerful reminder of the emotional and practical challenges faced by families dealing with childhood cancer. Her story underscores the importance of increased funding and research to combat this devastating disease, leaving a lasting impact on the lives of countless families.
